Xvivo Perfusion 過去の業績
過去 基準チェック /46
Xvivo Perfusionは、平均年間68.4%の収益成長を遂げていますが、 Medical Equipment業界の収益は、年間 成長しています。収益は、平均年間22.9% 30.8%収益成長率で 成長しています。 Xvivo Perfusionの自己資本利益率は9.8%であり、純利益率は27.2%です。
主要情報
68.4%
収益成長率
66.8%
EPS成長率
Medical Equipment 業界の成長 | 6.2% |
収益成長率 | 30.8% |
株主資本利益率 | 9.8% |
ネット・マージン | 27.2% |
次回の業績アップデート | 28 Jan 2025 |
最近の業績更新
Xvivo Perfusion (STO:XVIVO) Is Posting Healthy Earnings, But It Is Not All Good News
Nov 04We Think That There Are Issues Underlying Xvivo Perfusion's (STO:XVIVO) Earnings
Feb 01Recent updates
Xvivo Perfusion (STO:XVIVO) Is Posting Healthy Earnings, But It Is Not All Good News
Nov 04Results: Xvivo Perfusion AB (publ) Beat Earnings Expectations And Analysts Now Have New Forecasts
Oct 27With Xvivo Perfusion AB (publ) (STO:XVIVO) It Looks Like You'll Get What You Pay For
Oct 25Is There An Opportunity With Xvivo Perfusion AB (publ)'s (STO:XVIVO) 40% Undervaluation?
Aug 03Xvivo Perfusion AB (publ) (STO:XVIVO) Stock Rockets 34% As Investors Are Less Pessimistic Than Expected
Apr 25There Are Reasons To Feel Uneasy About Xvivo Perfusion's (STO:XVIVO) Returns On Capital
Apr 11Need To Know: Analysts Just Made A Substantial Cut To Their Xvivo Perfusion AB (publ) (STO:XVIVO) Estimates
Feb 05We Think That There Are Issues Underlying Xvivo Perfusion's (STO:XVIVO) Earnings
Feb 01Earnings Beat: Xvivo Perfusion AB (publ) Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Jan 28Returns On Capital At Xvivo Perfusion (STO:XVIVO) Have Stalled
Aug 24Why Xvivo Perfusion AB (publ) (STO:XVIVO) Could Be Worth Watching
Jul 17Do Xvivo Perfusion's (STO:XVIVO) Earnings Warrant Your Attention?
Jun 16Xvivo Perfusion (STO:XVIVO) May Have Issues Allocating Its Capital
Apr 19Are Investors Undervaluing Xvivo Perfusion AB (publ) (STO:XVIVO) By 21%?
Mar 23With EPS Growth And More, Xvivo Perfusion (STO:XVIVO) Makes An Interesting Case
Mar 07When Should You Buy Xvivo Perfusion AB (publ) (STO:XVIVO)?
Feb 13Be Wary Of Xvivo Perfusion (STO:XVIVO) And Its Returns On Capital
Dec 14Is There An Opportunity With Xvivo Perfusion AB (publ)'s (STO:XVIVO) 35% Undervaluation?
Nov 17Xvivo Perfusion (STO:XVIVO) Might Be Having Difficulty Using Its Capital Effectively
Aug 20Statutory Profit Doesn't Reflect How Good Xvivo Perfusion's (STO:XVIVO) Earnings Are
Jul 21Be Wary Of Xvivo Perfusion (STO:XVIVO) And Its Returns On Capital
Mar 30At kr258, Is Xvivo Perfusion AB (publ) (STO:XVIVO) Worth Looking At Closely?
Feb 18A Look At The Fair Value Of Xvivo Perfusion AB (publ) (STO:XVIVO)
Jan 30収支内訳
収支内訳
Xvivo Perfusion の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
---|---|---|---|---|
30 Sep 24 | 751 | 204 | 358 | 144 |
30 Jun 24 | 699 | 121 | 342 | 140 |
31 Mar 24 | 643 | 100 | 328 | 140 |
31 Dec 23 | 598 | 92 | 309 | 136 |
30 Sep 23 | 573 | 24 | 296 | 109 |
30 Jun 23 | 524 | 27 | 274 | 98 |
31 Mar 23 | 463 | 28 | 247 | 79 |
31 Dec 22 | 415 | 18 | 223 | 69 |
30 Sep 22 | 370 | 30 | 211 | 61 |
30 Jun 22 | 328 | 23 | 186 | 55 |
31 Mar 22 | 293 | 7 | 171 | 58 |
31 Dec 21 | 258 | 8 | 153 | 54 |
30 Sep 21 | 233 | -24 | 135 | 65 |
30 Jun 21 | 221 | -37 | 137 | 66 |
31 Mar 21 | 192 | -44 | 116 | 63 |
31 Dec 20 | 180 | -44 | 108 | 67 |
30 Sep 20 | 182 | -26 | 95 | 58 |
30 Jun 20 | 194 | -6 | 79 | 64 |
31 Mar 20 | 220 | 12 | 87 | 65 |
31 Dec 19 | 221 | 5 | 93 | 63 |
30 Sep 19 | 217 | 12 | 86 | 57 |
30 Jun 19 | 203 | 7 | 86 | 52 |
31 Mar 19 | 193 | 9 | 79 | 51 |
31 Dec 18 | 188 | 13 | 70 | 48 |
30 Sep 18 | 171 | 13 | 68 | 45 |
30 Jun 18 | 162 | 13 | 67 | 43 |
31 Mar 18 | 153 | 10 | 62 | 41 |
31 Dec 17 | 148 | 6 | 64 | 39 |
30 Sep 17 | 145 | 0 | 60 | 40 |
30 Jun 17 | 145 | 0 | 63 | 41 |
31 Mar 17 | 142 | 0 | 61 | 39 |
31 Dec 16 | 138 | 2 | 56 | 37 |
30 Sep 16 | 132 | 5 | 56 | 34 |
30 Jun 16 | 127 | 7 | 46 | 32 |
31 Mar 16 | 122 | 6 | 46 | 32 |
31 Dec 15 | 120 | 5 | 45 | 31 |
30 Sep 15 | 113 | 4 | 42 | 33 |
30 Jun 15 | 109 | 4 | 40 | 31 |
31 Mar 15 | 98 | 3 | 37 | 26 |
31 Dec 14 | 85 | 5 | 34 | 23 |
30 Sep 14 | 79 | 6 | 33 | 18 |
30 Jun 14 | 74 | 7 | 32 | 17 |
31 Mar 14 | 71 | 7 | 30 | 16 |
31 Dec 13 | 69 | 8 | 29 | 15 |
質の高い収益: XVIVO 非現金収入 のレベルが高いです。
利益率の向上: XVIVOの現在の純利益率 (27.2%)は、昨年(4.2%)よりも高くなっています。
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: XVIVOの収益は過去 5 年間で年間68.4%増加しました。
成長の加速: XVIVOの過去 1 年間の収益成長率 ( 748.3% ) は、5 年間の平均 ( 年間68.4%を上回っています。
収益対業界: XVIVOの過去 1 年間の収益成長率 ( 748.3% ) はMedical Equipment業界31%を上回りました。
株主資本利益率
高いROE: XVIVOの 自己資本利益率 ( 9.8% ) は 低い とみなされます。